The news is currently covering a major US Food and Drug Administration (FDA) recall of the medication Zantac and its generic equivalents. However, another word is being used that consumers may not be familiar with – ranitidine.
At the SMA Law Group, we are closely watching Zantac cases and are ready to help clients who may have been diagnosed with cancer due to using this medication. Here, our Pittsburgh Zantac cancer lawyers want to discuss what ranitidine is and how this relates to the recalls.
Ranitidine and How It Relates to The Zantac Recalls
Many people have heard that Zantac has been recalled at the request of the FDA. This request happened on April 1, 2020, after the FDA said that testing has indicated that the product may contain unsafe levels of N-nitrosodimethylamine (NDMA), a known cancer-causing carcinogen for humans. This recall request is for those prescription and over-the-counter versions of Zantac.
However, the FDA recall request is filled with references to ranitidine. It is vital that consumers understand that ranitidine is simply a generic version of Zantac. This is the same medication under a different label.
To be clear, The FDA recall request is for all ranitidine products, one of which is Zantac. If you are unsure about whether or not your medication contains ranitidine, please look at the label. Not only will your medication say whether or not it contains ranitidine on the front of the package, but it will also say this on the ingredients listed on the back of the box or bottle.
Ranitidine is most commonly used to treat heartburn and other stomach and intestinal issues a person may have. Ranitidine belongs in a class of drugs called H2 blockers and is typically taken by mouth with or without food once or twice a day.
The FDA was made aware of potential issues with ranitidine after testing conducted by independent laboratories discovered the unsafe levels of NDMA. According to the FDA, the daily safe consumption limit of NDMA is 96 nanograms. However, independent testing of Zantac and other ranitidine products found NDMA levels as high as 2,500,000 nanograms of the carcinogen in a single dosage. According to the FDA, the potential for high levels of NDMA contamination increases over time and if the product is stored at temperatures higher than room temperature.
At the SMA Law Group, we cannot stress this enough – do not take Zantac or other ranitidine products. If you are ill or have been diagnosed with cancer, speak to an attorney as soon as possible.
Let Us Get To Work On Your Case
If you or somebody you care about has become ill or been diagnosed with cancer after taking Zantac, contact an attorney today. At the SMA Law Group, our qualified and experienced product liability attorneys will investigate your case and work to secure any compensation you are entitled to, including:
- Cost of your current and future medical costs
- Lost income and benefits if you are unable to work
- Pain and suffering damages
- Loss of enjoyment of life damages
- Punitive damages against the maker of Zantac or the generic versions of the medication